146 results on '"Bos, Eelke M."'
Search Results
2. Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial
3. Towards clinical implementation of an AI-algorithm for detection of cervical spine fractures on computed tomography
4. Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
5. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study
6. Towards clinical implementation of an AI-algorithm for detection of cervical spine fractures on computed tomography
7. Investigating the Radiobiological Response to Peptide Receptor Radionuclide Therapy Using Patient-Derived Meningioma Spheroids.
8. MRI-Based Assessment of Brain Tumor Hypoxia: Correlation with Histology
9. Fatal Subarachnoid Hemorrhage from an Aneurysm of a Persistent Primitive Hypoglossal Artery: Case Series and Literature Overview
10. Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE
11. The prevalence and severity of fatigue in meningioma patients and its association with patient-, tumor- and treatment-related factors
12. MRI-Based Assessment of Brain Tumor Hypoxia: Correlation with Histology.
13. The prevalence and severity of fatigue in meningioma patients and its association with patient-, tumor-and treatment-related factors
14. Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma:a first-in-human phase 1 dose escalation trial
15. Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups
16. Epidemiology of adult meningioma: Report from the Dutch Brain Tumour Registry (2000–2019).
17. Pro-Differentiation Anticancer Therapy Using Local Delivery of hrBMP4 in Patients with Recurrent Glioblastoma: A First-in-Human Phase 1 Dose Escalation Trial
18. Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
19. Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups
20. Reconstructing human cerebral vasculature in 3D with high frame rate, freehand 2D Doppler ultrasound using optical tracking
21. Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups.
22. Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma.
23. Overexpression of Cystathionine γ-Lyase Suppresses Detrimental Effects of Spinocerebellar Ataxia Type 3
24. Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia
25. Intraoperative B-Mode Ultrasound Guided Surgery and the Extent of Glioblastoma Resection: A Randomized Controlled Trial
26. Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE
27. Intraoperative B-Mode Ultrasound Guided Surgery and the Extent of Glioblastoma Resection:A Randomized Controlled Trial
28. Fighting Oxidative Stress with Sulfur: Hydrogen Sulfide in the Renal and Cardiovascular Systems
29. Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects
30. COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
31. Fighting Oxidative Stress with Sulfur: Hydrogen Sulfide in the Renal and Cardiovascular Systems
32. Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE
33. Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury
34. GASEOUS HYDROGEN SULFIDE (H2S) IS PROTECTIVE DURING CARDIAC ISCHEMIA/REPERFUSION: RO-078
35. CYSTATHIONINE γ-LYASE IS AN ENDOGENOUS MODULATOR OF OXIDATIVE STRESS: O-175
36. A Large Skull Defect Due to Gorham-Stout Disease: Case Report and Literature Review on Pathogenesis, Diagnosis, and Treatment
37. Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury
38. Poster Board #-Session: P90-II Hydrogen Sulfide (H2S) Induced Hypometabolism Minimizes Renal Ischemia/Reperfusion Injury.: Abstract# 1070
39. Poster Board #-Session: P98-II 5'-Adenosine Monophosphate (5'-AMP) Induced Hypometabolism Protects Against Renal Ischemia/Reperfusion Injury (IRI) in Mice.: Abstract# 1078
40. Poster Board #-Session: P86-II ARA290 Protects Against Renal Ischemia/Reperfusion Injury.: Abstract# 1066
41. Brain death induces renal expression of heme oxygenase-1 and heat shock protein 70
42. A Case of Spontaneous Third Ventriculocisternostomy to the Interpeduncular Fossa
43. Two-Stage Cranioplasty: Tissue Expansion Directly over the Craniectomy Defect Prior to Cranioplasty
44. Sodium thiosulfate attenuates angiotensin II-induced hypertension, proteinuria and renal damage
45. Hydrogen sulfide attenuates angiotensin II-induced hypertension, proteinuria and renal damage
46. The role of hydrogen sulfide in aging and age-related pathologies
47. Out-of-Body Experience During Awake Craniotomy
48. Supplementary data for article: Snijder, P. M.; Baratashvili, M.; Grzeschik, N. A.; Leuvenink, H. G. D.; Kuijpers, L.; Huitema, S.; Schaap, O.; Giepmans, B. N. G.; Kuipers, J.; Miljkovic, J. L.; et al. Overexpression of Cystathionine γ-Lyase Suppresses Detrimental Effects of Spinocerebellar Ataxia Type 3. Molecular Medicine 2015, 21, 758–768. https://doi.org/10.2119/molmed.2015.00221
49. Overexpression of Cystathionine gamma-Lyase Suppresses Detrimental Effects of Spinocerebellar Ataxia Type 3
50. Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.